Adherencia farmacológica y prevención secundaria cardiovascular: una de las principales barreras en el tratamiento de la enfermedad ateroesclerótica: posición del Departamento de Prevención Cardiovascular de SOCHICAR en el uso de la polipíldora en prevención secundaria / Adherence to pharmacologic treatment in secondary prevention of cardiovascular disease
Rev. chil. cardiol
;
35(3): 270-282, 2016. tab
Article
in Spanish
| LILACS
| ID: biblio-844301
ABSTRACT
This paper outlines the position of the Department of Cardiovascular Prevention from the Chilean Society of Cardiology regarding the use of the "polypill". The international and local evidence regarding the benefits of the polypill compared to conventional therapy is reviewed. The benefits and some limitations of the polypill are outlined, along with cost-effective considerations. The increased adherence to treatment and the better clinical results of this strategy are put forward. The used of the polypill in different groups of subjects, especially those recovered from a recent myocardial in-farction, is recommended for individual patients and in Chilean cardiovascular prevention programs from the Ministry of Health.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Cardiovascular Agents
/
Cardiovascular Diseases
/
Atherosclerosis
/
Medication Adherence
Type of study:
Etiology study
Limits:
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. chil. cardiol
Journal subject:
Cardiology
Year:
2016
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Sociedad Chilena de Cardiología y Cirugía Cardiovascular/CL
Similar
MEDLINE
...
LILACS
LIS